Latest in Cardiology from ACC.org
- Pulsed Field Ablation Noninferior to Cryoablation For Paroxysmal AFibPulsed field ablation (PFA) is noninferior to cryoablation for the incidence of a first recurrence of atrial tachyarrhythmia in patients with paroxysmal atrial fibrillation (AFib), according to results from the SINGLE SHOT CHAMPION trial...
- Sharp Increase in Use of Tirzepatide, GLP1 RAs and SGLT2 inhibitors, As Conventional Alternatives DeclineAmong adults with type 2 diabetes (T2D), the use of tirzepatide along with GLP-1 RAs and SGLT2 inhibitors as glucose-lowering medication (GLM) has increased sharply, along with an increased use of tirzepatide and GLP-1 RAs as weight-lowering medication (WLM)...
- New HRS/ACC Scientific Statement Offers Guidance on Same-Day Discharge For Intracardiac Catheter AblationWith an increasing shift towards same-day discharge (SDD) as a means of improving access for an increasing number of patients undergoing intracardiac catheter ablation, a new Scientific Statement from the Heart Rhythm Society (HRS) and the ACC...
- PROSPECT II: High hsCRP Level Indicates High-Risk Vulnerable Plaque Post NSTEMIA high baseline level of high-sensitivity C-reactive protein (hsCRP) may indicate pan-coronary atherosclerosis and focal high-risk plaques in patients with a recent NSTEMI, according to a substudy of PROSPECT II published April 23...
- Beyond Glycemic Control: Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist to Reduce the Burden of Peripheral Artery DiseaseOver the past decade, lipid-lowering therapies have established the low-density lipoprotein-cholesterol dogma of the lower, the earlier, the longer, the better as the cornerstone of pharmacological prevention for atherosclerotic cardiovascular disease (ASCVD).